#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicular lymphoma stage II Tourette's disorder Anaemia Cytomegalovirus infection Fibrosarcoma Renal cell carcinoma Salivary gland cancer Neuroendocrine carcinoma metastatic Polycythaemia vera Congenital absence of bile ducts Hypoxic-ischaemic encephalopathy Infertility female Pneumonia Laryngeal squamous cell carcinoma Synovitis More trials…

    Learn about Rare Diseases

    Nephroblastoma – Diagnostics Ocular melanoma Primary biliary cholangitis – Life with Disease Familial amyotrophic lateral sclerosis – Basic Information Pemphigoid – Treatment Pulmonary sarcoidosis – Diagnostics Primary biliary cholangitis – Trials in Disease Nephrotic syndrome – Treatment Glomerulonephritis membranoproliferative – Trials in Disease Alternating hemiplegia of childhood – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Brivaracetam Bgb-A445 Niflumic Acid Afatinib Everolimus Cefoxitin Istaroxime Viltolarsen Dimethyl Fumarate Fenoterol Hydrobromide Dopamine Hydrochloride Bosentan FLUCLOXACILLIN SODIUM GSKVX000000044501 Belzupacap Sarotalocan ULVIPRUBART Eribulin Tetracaine Hydrochloride Islatravir DUVELISIB More therapies…

    Learn about Your Condition

    Richter's syndrome Viral myocarditis Vaginal haemorrhage Cervix carcinoma stage II Placenta praevia Myotonia Restless legs syndrome Carpal tunnel syndrome Malabsorption Pyoderma Gastrectomy Oedema Partial lipodystrophy Osteochondrodysplasia Ankylosing spondylitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of anakinra and a drug combination to prevent blood clots in patients receiving a pancreatic transplant

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Etanercept
    • Anakinra
    • Tacrolimus
    France

  • OM336 for Desensitization in Patients with End-Stage Renal Failure Awaiting Kidney Transplantation

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Valaciclovir
    • Buclizine Hydrochloride
    • Codeine Phosphate
    Austria

  • Psilocybin and pimavanserin for adults with major depressive disorder

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Psilocybine
    Spain

  • Study on the Safety and Effectiveness of OD-07656 and Vedolizumab for Patients with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Vedolizumab
    Austria Belgium Croatia Czechia Hungary Lithuania +1

  • Study on the Effects of Rapcabtagene Autoleucel and Drug Combination for Patients with Severe Refractory Inflammatory Muscle Diseases

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Immune-mediated myositis
    Investigated Drugs:
    • Rapcabtagene Autoleucel
    • Tacrolimus
    • Cyclophosphamide
    Austria Belgium Czechia Finland France Germany +7

  • Study of Ipilimumab and Nivolumab with or without Radiotherapy for Patients with Melanoma Brain Metastases

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    Italy
Previous Page
1 … 909 910 911 912 913 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!